# A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of AL-335

> **NCT02894905** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 24 (actual)

## Conditions studied

- Renal Insufficiency

## Interventions

- **DRUG:** AL-335

## Key facts

- **NCT ID:** NCT02894905
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-13
- **Primary completion:** 2017-08-08
- **Final completion:** 2017-08-16
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02894905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02894905, "A Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of AL-335". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02894905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*